Table 5 The clinical status of disease by stage and type of referral among patients with urogenital cancer
From: Symptoms and signs of urogenital cancer in primary care
Type of cancer, with location | Clinical status at follow-up | Status after Fast track | Status after Urgent referral | ||||||
|---|---|---|---|---|---|---|---|---|---|
Feeling well or stable disease | Progressive disease or dead | Unknown | Feeling well or stable disease | Progressive disease or dead | Unknown | Feeling well or stable disease | Progressive disease or dead | Unknown | |
Bladder (N = 30) | |||||||||
Localised: 16 (53%) | 14 (88%) | 1 (6%) | 1 | 3 | 1 | 1 | 1 | ||
Not localised: 11 (37%) | 9 (82%) | 2 (18%) | 2 | 1 | 2 | ||||
Unknown: 3 | 1 | 2 | 1 | ||||||
Kidney (N = 16) | |||||||||
Localised: 7 (44%) | 5 (71%) | 0 | 2 | 1 | 1 | 2 | |||
Not localised: 8 (50%) | 3 (38%) | 5 (63%) | |||||||
Unknown | 1 | ||||||||
Prostate (N = 56) | |||||||||
Localised: 31 (55%) | 26 (84%) | 1 (3%) | 5 | ||||||
Not localised: 18(32%) | 14 (78%) | 4 (22%) | 6 | 1 | |||||
Unknown 7 | 5 | 1 | 1 | 1 | |||||
Cervix uteri (N = 10) | |||||||||
Localised: 4 (40%) | 4 (100%) | 0 | 1 | ||||||
Not localised: 5 (50%) | 3 (60%) | 2 (40%) | 1 | 1 | 1 | ||||
Unknown: 1 | 1 | ||||||||
Corpus uteri (N = 14) | |||||||||
Localised: 10 (71%) | 9 (90%) | 1 (10%) | 3 | 3 | |||||
Not localised: 2 (14%) | 2 (100%) | 0 | |||||||
Unknown: 2 | 2 | ||||||||
Ovary (N = 8) | |||||||||
Localised: 4 (50%) | 4 (100%) | 0 | 3 | ||||||
Not localised: 4 (50%) | 1 (25%) | 3 (75%) | 1 | ||||||